2008
DOI: 10.1002/erv.884
|View full text |Cite
|
Sign up to set email alerts
|

Binge eating disorder pharmacotherapy clinical trails—who is left out?

Abstract: Given the complexity of BED, future pharmacotherapy studies should examine a broader range of subjects, including subjects with subthreshold forms of BED, those with comorbid disorders and elderly subjects.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 36 publications
1
14
0
Order By: Relevance
“…Future studies should examine a broader range of subjects, including subjects with subthreshold forms of BED, and normal weight BED, also with comorbid disorders [81]. Furthermore, they should focus on ED symptomatology rather than weight, for instance considering days in which the patient is abstinent from binge eating as the main outcome measure rather than frequency of binge itself.…”
Section: Discussionmentioning
confidence: 99%
“…Future studies should examine a broader range of subjects, including subjects with subthreshold forms of BED, and normal weight BED, also with comorbid disorders [81]. Furthermore, they should focus on ED symptomatology rather than weight, for instance considering days in which the patient is abstinent from binge eating as the main outcome measure rather than frequency of binge itself.…”
Section: Discussionmentioning
confidence: 99%
“…The patients with this latter condition were defined as having subthreshold BED (s-BED) [31,32]. Exclusion criteria were: a comorbid, full-syndrome axis I disorder (psychosis, mania, organic dementia, alcohol or other drug abuse, and suicide risk) other than depression, and obesity secondary to endocrinologic or metabolic disorders.…”
Section: Methodsmentioning
confidence: 99%
“…s-BED patients were defined as those who engaged in binge eating without fulfilling all diagnostic requirements for BED (Guerdjikova and McElroy, 2009). …”
Section: Discussionmentioning
confidence: 99%
“…The aim of this study was to test the efficacy of duloxetine over a period of 3 months in obese binge eating subjects who satisfied the full criteria for BED (APA, 2000) and in subjects with sub-threshold binge eating (s-BED) (Guerdjikova and McElroy, 2009) but high eating impulsivity. We focused our attention on eating pathology as the primary outcome (number of binges per week and scores on the binge eating scale (BES)).…”
Section: Introductionmentioning
confidence: 99%